STOCK TITAN

[Form 4] Zoetis Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Zoetis Inc. (ZTS) filed a Form 4 showing that an Executive Vice President reported an acquisition of derivative securities on 10/10/2025. The transaction involved Phantom Stock Units with Transaction Code A (acquired).

The filing lists 204.6185 derivative securities acquired and a Price of Derivative Security of $46.71. The units reference Zoetis common stock; the table shows underlying Common Stock of 67.7325 shares associated with the derivative entry. Following these transactions, the reporting person beneficially owned 10,990.0773 derivative securities, held directly.

According to the plan description, these phantom stock units were acquired under the Zoetis Supplemental Savings Plan, are settled in cash after separation from service, and may be transferred into alternative investment funds, subject to Zoetis’ ability to limit timing and frequency of transfers.

Zoetis Inc. (ZTS) ha presentato un Modulo 4 indicando che un Senior Vice President ha riportato un'acquisizione di titoli derivati il 10/10/2025. La transazione riguardava Unità azionarie fantasma con Codice di Transazione A (acquisito).

La presentazione elenca 204.6185 titoli derivati acquisiti e un Prezzo del Titolo Derivato di 46,71 USD. Le unità fanno riferimento al titolo comune di Zoetis; la tabella mostra azioni ordinarie sottostanti di 67.7325 azioni associate alla voce derivata. A seguito di queste transazioni, la persona reportante deteneva beneficiariamente 10.990,0773 titoli derivati, detenuti direttamente.

Secondo la descrizione del piano, queste unità di stock fantasma sono state acquisite nell'ambito del Zoetis Supplemental Savings Plan, si regolano in contanti dopo la separazione dal servizio, e possono essere trasferite in fondi di investimento alternativi, soggetti alla capacità di Zoetis di limitare tempistiche e frequenza dei trasferimenti.

Zoetis Inc. (ZTS) presentó un Formulario 4 que indica que un Vicepresidente Ejecutivo reportó una adquisición de valores derivados el 10/10/2025. La transacción involucró Unidades de Acciones Fantasma con Código de Transacción A (adquirido).

El archivo de presentación lista 204.6185 valores derivados adquiridos y un Precio del Valor Derivado de $46.71. Las unidades hacen referencia a las acciones comunes de Zoetis; la tabla muestra Acciones Comunes de 67.7325 acciones subyacentes asociadas a la entrada derivada. Después de estas transacciones, la persona informante poseía beneficiosamente 10,990.0773 valores derivados, mantenidos directamente.

Según la descripción del plan, estas unidades de acciones fantasma fueron adquiridas bajo el Zoetis Supplemental Savings Plan, se liquidan en efectivo después de la separación del servicio, y pueden transferirse a fondos de inversión alternativos, sujeto a la capacidad de Zoetis para limitar el momento y la frecuencia de las transferencias.

Zoetis Inc. (ZTS) 가 Form 4를 제출했다로 나타났으며, 임원급 부사장이 2025년 10월 10일에 파생증권의 취득을 보고했다. 거래는 팬텀 주식단위거래 코드 A획득되었다.

파일링은 취득된 파생증권 204.6185건과 파생증권 가격이 46.71달러를 목록화한다. 이 단위는 Zoetis 보통주를 참조하며 표에는 파생 항목과 관련된 기초 보통주 67.7325주가 표시된다. 이러한 거래 후 보고자는 10,990.0773의 파생증권을 직접 보유했다.

계획 설명에 따르면 이 팬텀 주식단위는 Zoetis Supplemental Savings Plan에 따라 취득되었고, 서비스 종료 후 현금으로 정산되며, Zoetis가 이전 및 전송의 시기와 빈도를 제한할 수 있는 조건 하에 대체 투자 펀드로의 이전이 가능하다.

Zoetis Inc. (ZTS) a déposé un Formulaire 4 indiquant qu'un vice-président exécutif a signalé une acquisition de valeurs dérivées le 10/10/2025. La transaction concernait des Unité d’Actions Fantômes avec le Code de Transaction A (acquis).

Le dossier indique 204,6185 valeurs dérivées acquises et un Prix de la Valeur Dérivée de 46,71 USD. Les unités font référence à l’action ordinaire de Zoetis ; le tableau montre les Actions Ordinaires de 67,7325 sous-jacentes associées à l’entrée dérivée. Suite à ces transactions, la personne déclarant détenait bénéficiairement 10,990.0773 valeurs dérivées, détenues directement.

Selon la description du plan, ces unités d’actions fantômes ont été acquises dans le cadre du Zoetis Supplemental Savings Plan, sont réglées en espèces après la séparation du service, et peuvent être transférées vers des fonds d’investissement alternatifs, sous réserve de la capacité de Zoetis à limiter le moment et la fréquence des transferts.

Zoetis Inc. (ZTS) hat ein Formular 4 eingereicht, das zeigt, dass ein Executive Vice President den Erwerb derivater Wertpapiere am 10.10.2025 gemeldet hat. Die Transaktion betraf Phantom Stock Units mit Transaktionscode A (erworben).

Die Einreichung listet 204,6185 erworbene derivative Wertpapiere und einen Preis des Derivatwertpapiers von 46,71 USD auf. Die Einheiten beziehen sich auf Zoetis Stammaktien; in der Tabelle werden Stammaktien von 67,7325 als zugrunde liegende Aktien mit dem Derivateintrag angegeben. Nach diesen Transaktionen hielt die meldende Person nützlicherweise 10,990.0773 derivative Wertpapiere und besaß sie direkt.

Nach Planbeschreibung wurden diese Phantom-Stock-Einheiten unter dem Zoetis Supplemental Savings Plan erworben, werden nach der Trennung vom Dienst in bar abgewickelt und können in alternative Investmentfonds übertragen werden, vorbehaltlich Zoetis' Fähigkeit, Timing und Häufigkeit der Transfers zu beschränken.

شركة Zoetis Inc. (ZTS) قدمت نموذج 4 يظهر أن نائب رئيس تنفيذي أبلغ عن اكتساب أوراق مالية مشتقة في 10/10/2025. شملت الصفقة وحدات الأسهم الوهمية مع رمز المعاملة A (تم اكتسابها).

تسرد filing 204.6185 ورقة مشتقة مكتسبة وسعر الورقة المشتقة 46.71 دولار. تشير الوحدات إلى أسهم Zoetis العادية؛ يظهر الجدول أسهم عادية 67.7325 أسهم أساسية مرتبطة بالمدخل المشتق. بعد هذه المعاملات، كان الشخص المبلغ عنه يملك فائدة< b>10,990.0773 من الأوراق المشتقة، ومحتفظ بها مباشرة.

وفقاً للوصف الخطة، تم اكتساب هذه الوحدات من الأسهم الوهمية بموجب Zoetis Supplemental Savings Plan، ويتم تسويتها بالنقد بعد الفصل عن الخدمة، ويمكن نقلها إلى صناديق استثمار بديلة، رهناً بقدرة Zoetis على تقييد التوقيت وتكرار النقل.

Zoetis Inc.(ZTS)提交了 Form 4,显示一位执行副总裁报告在 2025/10/10 获得了衍生证券。该交易涉及 虚拟股票单位交易代码 A(已取得)。

该申报列出获得的衍生证券数量为 204.6185,衍生证券价格为 46.71 美元。这些单位指向 Zoetis 的普通股;表中显示与该衍生条目相关的基础普通股为 67.7325 股。在这些交易之后,报告人实际拥有 10,990.0773 只衍生证券,直接持有

根据计划描述,这些虚拟股票单位是在 Zoetis Supplemental Savings Plan 下取得的,离职后以现金结清,并可转入其他投资基金,前提是 Zoetis 能限制转移的时机和频率。

Positive
  • None.
Negative
  • None.

Zoetis Inc. (ZTS) ha presentato un Modulo 4 indicando che un Senior Vice President ha riportato un'acquisizione di titoli derivati il 10/10/2025. La transazione riguardava Unità azionarie fantasma con Codice di Transazione A (acquisito).

La presentazione elenca 204.6185 titoli derivati acquisiti e un Prezzo del Titolo Derivato di 46,71 USD. Le unità fanno riferimento al titolo comune di Zoetis; la tabella mostra azioni ordinarie sottostanti di 67.7325 azioni associate alla voce derivata. A seguito di queste transazioni, la persona reportante deteneva beneficiariamente 10.990,0773 titoli derivati, detenuti direttamente.

Secondo la descrizione del piano, queste unità di stock fantasma sono state acquisite nell'ambito del Zoetis Supplemental Savings Plan, si regolano in contanti dopo la separazione dal servizio, e possono essere trasferite in fondi di investimento alternativi, soggetti alla capacità di Zoetis di limitare tempistiche e frequenza dei trasferimenti.

Zoetis Inc. (ZTS) presentó un Formulario 4 que indica que un Vicepresidente Ejecutivo reportó una adquisición de valores derivados el 10/10/2025. La transacción involucró Unidades de Acciones Fantasma con Código de Transacción A (adquirido).

El archivo de presentación lista 204.6185 valores derivados adquiridos y un Precio del Valor Derivado de $46.71. Las unidades hacen referencia a las acciones comunes de Zoetis; la tabla muestra Acciones Comunes de 67.7325 acciones subyacentes asociadas a la entrada derivada. Después de estas transacciones, la persona informante poseía beneficiosamente 10,990.0773 valores derivados, mantenidos directamente.

Según la descripción del plan, estas unidades de acciones fantasma fueron adquiridas bajo el Zoetis Supplemental Savings Plan, se liquidan en efectivo después de la separación del servicio, y pueden transferirse a fondos de inversión alternativos, sujeto a la capacidad de Zoetis para limitar el momento y la frecuencia de las transferencias.

Zoetis Inc. (ZTS) 가 Form 4를 제출했다로 나타났으며, 임원급 부사장이 2025년 10월 10일에 파생증권의 취득을 보고했다. 거래는 팬텀 주식단위거래 코드 A획득되었다.

파일링은 취득된 파생증권 204.6185건과 파생증권 가격이 46.71달러를 목록화한다. 이 단위는 Zoetis 보통주를 참조하며 표에는 파생 항목과 관련된 기초 보통주 67.7325주가 표시된다. 이러한 거래 후 보고자는 10,990.0773의 파생증권을 직접 보유했다.

계획 설명에 따르면 이 팬텀 주식단위는 Zoetis Supplemental Savings Plan에 따라 취득되었고, 서비스 종료 후 현금으로 정산되며, Zoetis가 이전 및 전송의 시기와 빈도를 제한할 수 있는 조건 하에 대체 투자 펀드로의 이전이 가능하다.

Zoetis Inc. (ZTS) a déposé un Formulaire 4 indiquant qu'un vice-président exécutif a signalé une acquisition de valeurs dérivées le 10/10/2025. La transaction concernait des Unité d’Actions Fantômes avec le Code de Transaction A (acquis).

Le dossier indique 204,6185 valeurs dérivées acquises et un Prix de la Valeur Dérivée de 46,71 USD. Les unités font référence à l’action ordinaire de Zoetis ; le tableau montre les Actions Ordinaires de 67,7325 sous-jacentes associées à l’entrée dérivée. Suite à ces transactions, la personne déclarant détenait bénéficiairement 10,990.0773 valeurs dérivées, détenues directement.

Selon la description du plan, ces unités d’actions fantômes ont été acquises dans le cadre du Zoetis Supplemental Savings Plan, sont réglées en espèces après la séparation du service, et peuvent être transférées vers des fonds d’investissement alternatifs, sous réserve de la capacité de Zoetis à limiter le moment et la fréquence des transferts.

Zoetis Inc. (ZTS) hat ein Formular 4 eingereicht, das zeigt, dass ein Executive Vice President den Erwerb derivater Wertpapiere am 10.10.2025 gemeldet hat. Die Transaktion betraf Phantom Stock Units mit Transaktionscode A (erworben).

Die Einreichung listet 204,6185 erworbene derivative Wertpapiere und einen Preis des Derivatwertpapiers von 46,71 USD auf. Die Einheiten beziehen sich auf Zoetis Stammaktien; in der Tabelle werden Stammaktien von 67,7325 als zugrunde liegende Aktien mit dem Derivateintrag angegeben. Nach diesen Transaktionen hielt die meldende Person nützlicherweise 10,990.0773 derivative Wertpapiere und besaß sie direkt.

Nach Planbeschreibung wurden diese Phantom-Stock-Einheiten unter dem Zoetis Supplemental Savings Plan erworben, werden nach der Trennung vom Dienst in bar abgewickelt und können in alternative Investmentfonds übertragen werden, vorbehaltlich Zoetis' Fähigkeit, Timing und Häufigkeit der Transfers zu beschränken.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Polzer Robert J

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Unit(1) (2) 10/10/2025 A 204.6185 (1) (1) Common Stock 67.7325 $46.71 10,990.0773 D
Explanation of Responses:
1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Zoetis (ZTS) disclose in this Form 4?

An Executive Vice President reported acquiring Phantom Stock Units on 10/10/2025 with Transaction Code A.

How many derivative securities were acquired in the reported transaction for ZTS?

The filing shows 204.6185 derivative securities acquired.

What is the price listed for the phantom units in the Zoetis Form 4?

The filing lists a Price of Derivative Security of $46.71.

How many derivative securities does the reporting person own after the transaction?

Beneficial ownership following the transaction is 10,990.0773 derivative securities, held directly.

What stock underlies the phantom units reported by Zoetis (ZTS)?

The derivative entry references Common Stock with an underlying amount of 67.7325 shares.

How are Zoetis phantom stock units settled?

Per the plan, they are settled in cash after the reporting person’s separation from service and may be reallocated into other funds subject to company limits.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

63.05B
442.76M
0.09%
98.66%
1.75%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY